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Abstract 
The metazoan protein BCL2-associated athanogene cochaperone 6 (Bag6) forms 
a hetero-trimeric complex with ubiquitin-like 4A (Ubl4A) and transmembrane domain 
recognition complex 35 (TRC35). This Bag6 complex is involved in tail-anchored protein 
targeting and various protein quality control pathways in the cytosol as well as regulating 
transcription and histone methylation in the nucleus. Here we present a crystal structure 
of Bag6 and its cytoplasmic retention factor TRC35, revealing that TRC35 is remarkably 
conserved throughout opisthokont lineage except at the C-terminal Bag6-binding groove, 
which evolved to accommodate a novel metazoan factor Bag6. Remarkably, while TRC35 
and its fungal homolog guided entry of tail-anchored protein 4 (Get4) utilize a conserved 
hydrophobic patch to bind their respective C-terminal binding partners Bag6 and Get5, 
Bag6 wraps around TRC35 on the opposite face relative to the Get4-5 interface. We 
further demonstrate that the residues involved in TRC35 binding are not only critical for 
occluding the Bag6 nuclear localization sequence from karyopherin  binding to retain 
Bag6 in the cytosol, but also for preventing TRC35 from succumbing to RNF126-mediated 
ubiquitylation and degradation. The results provide a mechanism for regulation of Bag6 
nuclear localization and the functional integrity of the Bag6 complex in the cytosol.  
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Tail-anchored (TA) membrane proteins, which comprise ~2% of eukaryotic genes, 
contain a single, C-terminal, hydrophobic transmembrane-helix domain (TMD) (1). The 
TMD, which acts as the endoplasmic reticulum (ER) targeting signal, only emerges from 
the ribosome after translation termination necessitating post-translational targeting and 
insertion. Transmembrane domain Recognition Complex (TRC) proteins in mammals and 
Guided Entry of Tail-anchored proteins (GET) in fungi are the best characterized 
molecular players in TA targeting (2, 3). In the TRC pathway, TA proteins are captured 
by small-glutamine-rich-tetratricopeptide-repeat protein A (SGTA) after release from the 
ribosome then transferred to the ATPase TRC40 facilitated by the hetero-trimeric Bag6 
complex (which contains Bag6, TRC35, Ubl4A) (4). TA binding stimulates hydrolysis of 
ATP by TRC40 (5) leading to release of the TRC40-TA complex that then localizes to the 
ER membrane via its interaction with CAML (6). Release of the TA substrate for insertion 
is facilitated by calcium modulating ligand (CAML) and tryptophan rich basic protein 
(WRB) (7). Notably, loss of WRB in mouse cardiomyocytes and hepatocytes results in 
partial mislocalization of TA proteins (8), suggesting that other pathways can compensate 
to target TA in vivo. Multiple pathways have been implicated in these alternative TA 
targeting pathways including the signal recognition particle (SRP) (9), SRP-independent 
targeting (SND) proteins (10), Hsc70 family of chaperones (11), and ubiquilins (12).  
Structural information for the mammalian proteins is sparse; however, homology 
to the equivalent fungal counterparts, Get1-5 and Sgt2, allow for clear parallels. Bag6 is 
unique among the mammalian proteins, as it appears relatively late in evolution (Fig. S2) 
and its introduction alters the molecular architecture of the central hand-off complex. For 
TA targeting, while functionally the heterotrimeric Bag6 complex is equivalent to the 
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fungal heterotetrameric Get4-Get5 complex (4, 13), the additional protein leads to new 
interactions. In yeast, Get5 (the Ubl4A homolog) has a C-terminal homodimerization 
domain and an N-terminal heterodimerization domain that forms a complex with Get4 (the 
TRC35 homolog) resulting in an extended heterotetramer (14, 15).  
Crystal structures of fungal Get4 revealed 14 α-helices in an α-solenoid fold that 
can be divided into an N-terminal and a C-terminal domain (NTD & CTD) (14, 16, 17) 
(Figs. 1A and S1A). The NTD contains conserved residues (Fig. S1C) involved in binding 
and regulating Get3 (13, 14), while the CTD forms a stable interaction with the Get5 N-
terminus (Get5-N) (14, 17). The Get5 interface includes a hydrophobic cleft in Get4 
formed by a -hairpin between 13 and 14 that binds the helix in Get5-N (14). Sequence 
alignment of Get4/TRC35 and Get5/Ubl4A led to predictions that the Get4 -hairpin and 
Get5 N-terminal extension are absent in metazoans (14) (Fig. 1B), which suggested a 
different structural organization for the metazoan Bag6-TRC35-Ubl4A complex.  
Indeed, in metazoans, Bag6 abrogates the interaction of TRC35 with Ubl4A by 
separately binding these factors (4, 14, 18) resulting minimally in a heterotrimer. The 
interface between TRC35 and Bag6 had previously been mapped to the CTD of TRC35 
and the region on Bag6 that contains the bipartite nuclear localization sequence (NLS) 
(4, 19, 20). Overexpression of TRC35 results in Bag6 retention in the cytosol (20), 
suggesting that TRC35 plays a role in determining the nucleo-cytoplasmic distribution of 
Bag6. Potential roles for Bag6 in the nucleus are varied and include modulation of p300 
acetylation (21-23), facilitation of histone methylation (24, 25), and regulation of DNA 
damage signaling-mediated cell death (26). How Bag6 localization is regulated remains 
unclear.  
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In this study, we present a crystal structure of a complex from humans that includes 
TRC35 and the TRC35-binding domain of Bag6. The structure of TRC35 reveals the 
conserved architecture relative to fungal Get4 homologs. Surprisingly, Bag6 utilizes the 
same conserved pockets on TRC35 that are recognized by Get5 on Get4; yet the 
extended domain wraps around the opposite face of the α-solenoid. The resulting 
interaction leads to masking of the bipartite NLS preventing nuclear trafficking of Bag6 by 
blocking binding to karyopherin α (KPNA), which is demonstrated experimentally. The 
interaction also prevents RNF126-mediated degradation of TRC35. The combined results 
suggest a mechanism for regulation of Bag6 nucleo-cytoplasmic distribution.  
 
The crystal structure of TRC35 – Bag6-NLS complex 
A complex between TRC35 (residues 23 to 305), previously shown to be 
competent for TA transfer (4), and a minimal TRC35-binding domain of Bag6 that contains 
the NLS (residues 1000-1054) was co-expressed, purified and crystallized. A dataset 
from a single crystal was collected to 1.8Å resolution and phases were obtained using 
single wavelength anomalous dispersion from a rubidium derivative. The final model 
refined to 1.8-40Å had good statistics with an Rwork=15.8% and an Rfree=20.1% and no 
residues in the disallowed region of the Ramachandran. Full crystallographic statistics 
are provided in Table S1. All TRC35 residues in the crystallized construct were visible in 
the electron density except for S137 and G138 that are disordered in the loop between 
6 and 7. For Bag6, residues 1002-1043 were resolved with only a few terminal residues 
ambiguous in the electron density.  
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TRC35 has the same overall architecture as the fungal Get4 structures (Fig. S1A), 
revealing that the Get4 fold has been conserved across Opisthokonta. Opisthokonta 
includes metazoan, choanozoan, and fungal lineages (Fig. S2), which share common 
ancestry as determined by analysis of 16S-like rRNA sequences (27) and several protein 
sequences (28). The first 15 -helices form an -solenoid fold that can be divided into N- 
and C-terminal halves (Fig. 1B). Alignment of the NTD between TRC35 and Get4 (PDB 
ID: 3LKU) results in an RMSD = 1.380Å for that region, while the equivalent alignment in 
the CTD results in an RMSD = 3.429Å (Fig. S1B). As seen in Get4 (14), there is likely 
some flexibility between these two halves based on differences across crystal forms. 
Get4/TRC35 and Get3/TRC40 are conserved throughout eukaryotic evolution and seem 
to occur as a pair in all opisthokonts, suggesting the essentiality of the two proteins in the 
pathway (Fig. S2). Consistent with this notion, residues at the TRC35-TRC40 interface 
(13) and the TRC35-Bag6 interface in TRC35 are highly conserved (Figs. S1C and S1D). 
As predicted from sequence alignment analysis, the -hairpin in Get4 is replaced by a 
shorter loop in TRC35 (Fig. 1C, arrows). In fact, sequence alignment of the predicted 
Get4 proteins of selected opisthokonts revealed that the -hairpin is unique to the fungal 
lineage (Figs. S2 and S3). The C-terminal 16 is flanked by two extended stretches that 
cover part of Bag6 (Fig. 1B).  
The Bag6 NLS region wraps around the TRC35-CTD (Fig. 1B, light pink) at an 
interface that resembles the interaction of Get5 with Get4 (Fig. 1C). The interaction is 
stabilized by two hydrophobic interface sites. In interface I, Bag6 1 and 2 dock into a 
conserved pocket created by 12 and 13 of TRC35 (Fig. S1D) and include W1004, 
V1008 and W1012 from Bag6 and V254, V257, F242, L258 and Y262 from TRC35 (Fig. 
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1D). In fungal Get4-5, the Get5 N-terminal helix docks into a groove formed by 12, 13, 
and the -hairpin of Get4 (Fig. 1C). The missing -hairpin in TRC35 results in the Bag6 
helix shifting away from 11 towards 12 and 13 near the bottom of TRC35 (Fig. 1C, 
arrows). The differences in the interface result in changes in the arrangement of 11, 
13, and 15 of TRC35 (Fig. 1C) relative to those of Get4. Interface II is less extensive 
involving fewer residues, L1032, Y1036, M1040 of Bag6 and F195, M271 of TRC35 (Fig. 
1D). While the connecting loops between the two interfaces are well-ordered in both 
contexts, the Bag6 loop makes fewer contacts to TRC35 than the extensive interactions 
in the Get5-loop to Get4 (Fig. 1B).  
The structure reveals how TRC35 masks the Bag6 bipartite NLS (Fig. 1B). The 
conserved first basic cluster of the predicted NLS (K1024RVK) is sequestered between 
interfaces I and II (Fig. 1B, sticks). Only the first lysine residue of the second cluster 
(K1043RRK) is resolved in our model (Fig. 1B, sticks). The truncated C-terminal residues 
of TRC35 in our construct are predicted to be disordered (29) and include conserved 
multiple negative charges (five Glu and three Asp (Fig. S3)) that would be in position to 
mask the second NLS basic cluster, K1043RRK, through charge-mediated interactions.  
 
Probing the Bag6-TRC35 Interface  
To validate the interfaces observed in the structure, we generated alanine mutants 
for analysis by yeast 2-hybrid analysis. A fragment of Bag6 (residues 951-1126) was 
attached to the GAL4 transcription activating domain and full-length TRC35 was attached 
to the GAL4 DNA-binding domain. The transformation of both vectors were confirmed by 
cell growth on SC-Ura-Leu plates (Fig. S4A & B). Of the single amino acid substitutions 
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(Figs. 2A, S4A & B), only one residue TRC35 (Y262A) at the end of interface I (Fig. 1D) 
disrupted the yeast 2-hybrid interaction (Fig. S4A). The Bag6 mutations W1004A and 
W1012A localize at interface I and Y1036A localizes at interface II. While the individual 
mutations did not show a phenotype, the combination of the two mutations 
(W1004A/Y1036A or W1012A/Y1036A) synthetically disrupted the interaction (Fig. 2A). 
For mutants that failed to grow, expression was confirmed by immunoblotting (Fig. S4C). 
The results confirm that both interfaces are critical for forming a stable complex between 
Bag6 and TRC35.  
We further validated the interaction of TRC35 with full length Bag6 in the context 
of a mammalian cellular environment. GFP-tagged wild-type (wt) Bag6 or the mutants 
Bag6(W1004A), Bag6(W1012), Bag6(Y1036A), Bag6(W1004A/Y1036A), and 
Bag6(W1012A/Y1036A) were co-expressed with FLAG-tagged TRC35 in CRISPR-
mediated Bag6 knock-out 293T cell (30). Bag6 and associated proteins were captured 
from detergent-derived cell extracts by immunoprecipitating using a GFP-antibody. 
Viewed by immunoblotting (Figs. 2B and S4D & E), each Bag6 mutation resulted in a 
reduction of the captured TRC35 relative to wtBag6 (compare lane 9 to lanes 10-12). The 
double mutants (lanes 13 &14) also had reduced capture of TRC35; however, by this 
assay they unexpectedly appeared to capture more TRC35 than the single mutants. In 
all the lanes, unexpected higher molecular weight TRC35 bands appeared that became 
more pronounced in the double mutants (Fig. 2 asterisk and S4D & E). This will be 
discussed below. Overall, the general effect of mutations at the Bag6 interface are 
consistent between the yeast 2-hybrid and the mammalian pull-downs.  
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Improperly assembled TRC35 is ubiquitylated by RNF126 
As noted above, examination of immunoprecipitation results (Figs. 2B and S4D & 
E) revealed two interesting observations: (1) an unexpected increase in TRC35 binding 
to Bag6 double mutants relative to single mutants (Fig. 2B and S4D & E, compare lanes 
11-12 vs. lanes 13-14) and (2) the appearance of higher molecular weight products of 
TRC35 captured by Bag6 double mutants (Figs. 2B and S4D & E, asterisk). Evidence in 
the literature supports that the stability of TRC35 requires forming a proper complex with 
Bag6 (18, 26). Given the implication of Bag6 as a chaperone holdase in protein quality 
control processes such as mis-localized protein degradation (31) and ER-associated 
protein degradation pathways (20, 32), we postulated that TRC35 mutants that fail to form 
a complex with Bag6 at its physiological binding site are unstable and become a target 
for Bag6-mediated degradation. In this case, unassembled TRC35 would become a target 
for Bag6 dependent degradation as a result from TRC35 binding to the Bag6 substrate-
binding site. Because the Bag6 construct used in our yeast 2-hybrid studies lacks the 
substrate binding domain, increased binding is not observed in the double mutant 
experiments. If this model is correct, the higher molecular weight bands observed in figure 
2 and S4D & E should be ubiquitylated TRC35 bound to an alternative substrate-binding 
site on Bag6.  
To verify a role for Bag6 in TRC35 degradation, Bag6 deficient cells were used to 
co-express TRC35, Bag6 variants and ubiquitin with the expectation that destabilized 
TRC35 would be ubiquitylated. Cells were transfected with TRC35•FLAG, Bag6•GFP, 
and HA•ubiquitin. Proteins bound to Bag6 were first immunoprecipitated with GFP 
antibody (Fig. S5 A & B, lanes 2-7). To remove other ubiquitylated Bag6 substrates (20, 
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33, 34), the samples obtained from the GFP immunoprecipitation were subject to a 
second round of immunoprecipitation using anti-FLAG beads under denaturing conditions 
(Fig. S5A & B, lanes 9-14).  Immunoblotting analysis of the samples from the first round 
of immunoprecipitation showed that all Bag6 variants pulled down ubiquitylated proteins, 
suggesting that these mutations did not affect its substrate-binding activity (Fig. S5A & B, 
lanes 2-7). After the second immunoprecipitation with FLAG antibody, TRC35 associated 
with wtBag6 carried a small amount of ubiquitin conjugates (Fig. S5A & B, lane 9) while 
those associated with Bag6 variants that disrupted physiological association with TRC35 
carried significantly more ubiquitin conjugates (Fig. S5A & B, lanes 10-14). Compared to 
single Bag6 mutations, TRC35 bound to the double mutants had the highest ubiquitin-
modified to unmodified TRC35 ratio (Fig. S5A & B, compare lanes 10-12 to 13-14).  
Furthermore, the level of TRC35 in cells expressing Bag6 double mutants was 
consistently lower than in cells expressing wtBag6 (Fig. S5C), which could be rescued by 
treatment with the proteasome inhibitor MG132 (Fig. 3A lane 2 vs. 4). Treating cells with 
a proteasome inhibitor also increased ubiquitylated TRC35 that was captured by either 
wtBag6 or a Bag6 double mutant (Fig. 3A).  The accumulation of unmodified TRC35 (Fig. 
3A lanes 9 & 10 vs 11 & 12) is probably due to depletion of free ubiquitin in the cell (35). 
Collectively, these data support the idea that the subset of TRC35 molecules unable to 
associate with Bag6 via the NLS domain are unstable and become targets for ubiquitin-
dependent degradation through a client-chaperone interaction with Bag6. This suggests 
that the ubiquitylated TRC35 associates with the quality control module (QC) of Bag6 
(36).  
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To further ensure that unassembled TRC35 is a Bag6-QC substrate, we 
investigated the effect of the ubiquitin ligase RNF126 on TRC35 ubiquitylation. RNF126 
is a Bag6-associated ubiquitin ligase utilized by the Bag6-QC for ubiquitylation of Bag6-
associated clients in the cytosol leading to their degradation by the proteasome (36). If 
TRC35 ubiquitylation is mediated by Bag6-QC, knocking down RNF126 in cells 
expressing Bag6 mutants would result in reduced ubiquitylation of TRC35, increasing its 
stability. To test this hypothesis, the effect of RNF126 and proteasome inhibition on 
TRC35 ubiquitylation and stability were examined. 
We examined the effect of siRNA-mediated RNF126 knockdown on TRC35 
ubiquitylation. 293T cells co-expressing HA•ubiquitin, TRC35•FLAG and either wt or 
mutant Bag6•GFP (W1004A/Y1036A or W1012A/Y1036A) were treated with siRNA 
against RNF126 followed by 6 hour treatment with MG132. Bag6-associated TRC35 was 
isolated by two rounds of immunoprecipitation. Immunoblotting was used to analyze the 
relative ratio between ubiquitylated TRC35 and unmodified TRC35 (Ub-TRC35/TRC35). 
The ratio in cells expressing both wtTRC35 and wtBag6 without RNF126 was defined as 
1. In cells expressing Bag6 mutants, ubiquitylation of TRC35 bound to Bag6 is moderately 
increased (Fig. 3B lane 9 vs. 10); knockdown of RNF126 reduces TRC35 ubiquitylation 
in cells expressing either wtBag6 or Bag6 double mutants, resulting in ~2-3-fold reduction 
in Ub-TRC35/TRC35 (Fig. 3B lanes 9 & 10 vs. 11 & 12). Importantly, like MG132 
treatment, knockdown of RNF126 rescued the expression of TRC35 in cells expressing 
the double mutant (Fig. S6), presumably due to increased stability. Together these results 
demonstrate that ubiquitylation of unassembled TRC35 is modulated by the quality 
control role of Bag6 and RNF126.  
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 TRC35 Masks the Bipartite Nuclear Localization Sequence of Bag6 and Retains 
Bag6 in the Cytosol 
To investigate the Bag6-TRC35 interface in the context of Bag6 localization, the 
mutants identified from yeast 2-hybrid and immunoprecipitation were used for localization 
studies. Overexpression of TRC35 has been shown to retain Bag6 in the cytosol (20), 
suggesting that TRC35 binding is required for cytosolic localization of Bag6. Because the 
mutations identified in our yeast 2-hybrid experiments specifically prevent TRC35 binding 
at its native binding site that contains the NLS, we postulated that exogenously expressed 
Bag6 mutants defective in TRC35 binding would localize primarily in the nucleus 
regardless of TRC35 expression. To test this hypothesis, wt and mutant Bag6 bearing a 
GFP tag were expressed in HeLa cells with or without TRC35•FLAG and the localization 
of Bag6 and TRC35 was examined by immunofluorescence.  
As expected (20), given the NLS, overexpressed wtBag6 and various Bag6 
mutants were localized to the nucleus (Fig. 4A). This is likely due to excess Bag6 that 
cannot be retained in the cytosol by endogenous TRC35. Indeed, when TRC35 is co-
expressed with wtBag6, the increased cytosolic pool of TRC35 captures wtBag6 and both 
proteins stain primarily in the cytosol (Fig. 4A). In accordance with the 
immunoprecipitation results (Fig. 2B), introduction of a single mutation—W1004A, 
W1012A, or Y1036A—results in some Bag6 localization to the nucleus (Fig. 4B, C, and 
D and table S3). Mutations at both interface I (W1004A or W1012A) and interface II 
(Y1036A) further reduce the binding affinity between Bag6 and TRC35 (Fig. 2) and Bag6 
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localizes primarily to the nucleus (Fig. 4E & F and table S3). These results unequivocally 
establish TRC35 as a cytoplasmic retention factor of Bag6.  
 
TRC35 has higher affinity for Bag6 than Karyopherin-α 2 (KPNA2)  
All molecules destined for the nucleus must move through the nuclear pore 
complex (NPC), a large assembly that spans the nuclear envelope and facilitates nucleo-
cytoplasmic traffic (37). Macromolecules larger than ~40 kDa cannot freely diffuse 
through the NPC and require carrier proteins, such as the karyopherin-α (KPNA) and -β 
families of transport receptors (38, 39). The two basic clusters, R1024KVK and K1043RRK 
(Fig. 5A), in Bag6 are thought to act as a bipartite NLS by specifically recognizing the 
acidic substrate-binding surface of karyopherins (19). In HeLa cells, the K1045R to S1045L 
mutation has been shown to abrogate nuclear localization of Bag6 (19). Therefore, 
TRC35 and KPNA likely bind Bag6 at the fragment that contains the NLS.  
To confirm that the Bag6-NLS is a KPNA binding site and to define the residues 
involved in KPNA binding, a Bag6 C-terminal 131 residues (Bag6C131) (40) in complex 
with hexahistidine-tagged full-length Ubl4A (Bag6C131-6xHis•Ubl4A) was purified from 
E. coli. KPNA2 was chosen specifically as it had been seen to interact with Bag6 (41) and 
could be stably purified. Mutations previously shown to abrogate Bag6 nuclear 
localization (19) were introduced at either the first basic cluster (1024SL) or the second 
basic cluster (1045SL) (Fig. 5A). The purified Bag6C131-6xHis•Ubl4A variants were 
incubated with either GST•TRC35 or MBP•KPNA2 lacking importin β binding domain (58-
529) and the resulting complexes were isolated using Ni-NTA beads. GST•TRC35 pulled 
down wild-type, 1024SL, and 1045SL Bag6C131-6xHis•Ubl4A with similar efficiency (Fig. 
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5B lanes 5-7), demonstrating that these residues are not involved in binding TRC35. 
MBP•KPNA2 formed a complex with Bag6 that can be visualized in a pull-down where 
MBP•KPNA2 captures wtBag6 (Fig. 5B lane 9). Surprisingly, binding was only sensitive 
to mutation of the second basic cluster which led to significant disruption of the interaction 
between Bag6C131-6xHis•Ubl4A and MBP•KPNA2 (Fig. 5B compare lane 10 and 11). 
These results show that the residues required for binding KPNA2 are distinct from those 
required for binding TRC35 despite localizing between key TRC35 binding residues. 
Moreover, unlike what had been previously suggested (19), the Bag6 NLS is monopartite 
with the second basic cluster both necessary and sufficient for binding KPNA2. The 
overlap of the two binding sites provides a simple mechanism for Bag6 retention in the 
cytoplasm where TRC35 prevents KPNA binding by occlusion. 
If binding of TRC35 to Bag6 prevents KPNA-mediated nuclear translocation, only 
TRC35-free Bag6 should be able to bind KPNA and be translocated to the nucleus. There 
are several ways in which this could be achieved. One such is that if KPNAs have a higher 
affinity for Bag6 than TRC35, upregulation of KPNA expression would lead to 
displacement of TRC35 from Bag6 and formation of a Bag6-KPNA complex. To test this, 
we compare the relative binding affinities of TRC35 and KPNA2 to Bag6 using an 
exchange assay. Bag6C131-6xHis•Ubl4A complexes with GST•TRC35 were generated 
and bound to glutathione affinity resin beads via the GST-tag. After washing, increasing 
amounts of MBP•KPNA2 were added to the bound beads. The ability of MBP•KPNA2 to 
displace Bag6C131-6xHis•Ubl4A from GST•TRC35 was determined by the amount of 
Bag6C131-6xHis•Ubl4A that was eluted from the resin after incubation. In this case, even 
at the highest concentration tested (2-fold molar excess), there was no significant 
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displacement of Bag6 from TRC35 by KPNA2 (Fig. 5C lanes 4-7). Performing the 
opposite experiment, starting with MBP•KPNA2-Bag6C131-6xHis•Ubl4A on amylose 
beads, adding excess GST•TRC35 resulted in the dissociation of the MBP•KPNA2-
Bag6C131-6xHis•Ubl4A complex (Fig. 5C lanes 11-14). These results highlight the 
stability of the TRC35-Bag6 complex and argue against the ability of KPNA regulation as 
a means for modulating the nuclear pool of Bag6.  
 
Discussion 
Bag6 is a critical scaffolding factor that forms a stable complex with TRC35 and 
Ubl4A and is involved in protein targeting, protein quality control, and transcription 
regulation. While there is ample evidence that Bag6 plays both cytosolic and nuclear 
roles, it is unclear how the localization of Bag6 is regulated. Here we report the structure 
of the Bag6 NLS-region bound to its cytosolic retention factor TRC35, and suggest a 
mechanism for the regulation of Bag6 localization.  
The remarkable conservation of TRC35 in both sequence (Fig. S3) and at the 
structural level (Fig. S1) from yeast to human can be attributed to the role of TRC35 as a 
hub of protein-protein interactions in the TRC pathway. The most important interaction, 
based on its complete conservation, is between TRC35 and TRC40 (Fig. S2) and likely 
drives evolution of components in the pathway. This interaction is critical for the regulation 
of TA protein transfer (4, 13, 42) and, as shown in fungal Get4, for release of Get3/TRC40 
from the ER membrane to restore the cytosolic pool of complex ready for TA protein 
transfer (43). The importance of linking TRC35 homologs to Ubl4A homologs is sustained 
in humans despite the loss of structural features that allow these two proteins to interact 
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with each other (14). In this case, the new component Bag6 is introduced, which acts as 
a scaffold to link TRC35 to Ubl4A. The Bag6-TRC35 structure reveals that TRC35 binds 
this novel binding partner utilizing conserved patches in a distinct fashion (Fig. 1). This 
led to the expansion of the TRC35 protein-protein interaction network while maintaining 
its crucial interaction with TRC40.  
Our results also show that TRC35 acts as an intermolecular mask to Bag6 NLS in 
a role similarly performed in other pathways. Examples of other cytosolic retention factor 
pairs include IκB and NF-κB (44), HIC and Rev (45) and BRAP2 that retains HMG20A 
(46). Unlike other cytoplasmic retention factors, which have only been shown to bind their 
target NLS-containing proteins for occlusion of the NLS, TRC35 also plays a distinct role 
in the cytoplasmic TA targeting and protein quality control when in complex with Bag6. 
This dual functionality may be evolutionarily conserved. One study showed that Ubl4A 
has a nuclear role of promoting STAT3 dephosphorylation (47). This study did not explore 
the localization of Bag6 relative to Ubl4A, but Ubl4A does not have a NLS and thus is 
likely to have been translocated with Bag6. In yeast, fungal Get4 binds the N-terminal 
domain of Get5, which appears to contain a functional NLS that directs Get5 to the 
nucleus during a ‘Get5-mediated stress response’ (48).  
These results allow speculation of possible regulatory mechanism for Bag6 nuclear 
localization. First, disrupting the Bag6-TRC35 interface by introducing alanine mutations 
led to ubiquitylation of TRC35 (Fig. S4), which is mediated by RNF126. Knocking down 
Bag6 has been shown to reduce levels of TRC35 in HeLa cells (26), suggesting that Bag6 
is required for TRC35 stability in vivo. We also showed that KPNA2 has a lower affinity 
for Bag6 than TRC35 (Fig. 5C), which suggests that for Bag6 to bind KPNA and 
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translocate into the nucleus, it needs to be free of TRC35. The most likely explanation is 
that cells regulate Bag6 localization by modulating Bag6 levels or decreasing TRC35 
levels. In humans, the Bag6 rs3117582 single nucleotide polymorphism found in the 
promoter region of Bag6 likely affect expression levels and is associated with higher 
incidence of lung cancer (49-51) and osteoarthritis (52). The localization could also be 
pre-translationally regulated with differential splicing. In brain and breast tissue, for 
instance, Bag6 isoforms that lack the NLS are expressed at higher levels than isoforms 
with the NLS (53).  
Our findings establish TRC35 as a universally conserved protein in the opisthokont 
lineage in both structure and function. These findings support the model in which TRC35 
is an important hub of a protein-protein interaction network with its interaction with TRC40 
at the core. Higher eukaryotes expanded on this network by the addition of Bag6. Our 
biochemical studies unequivocally establish TRC35 as a cytosolic retention factor of Bag6 
and suggest that Bag6 needs to be in excess for nuclear localization. However, how 
different cell types regulate Bag6 localization, whether the regulation can be mediated by 
specific stress, and the biological implications of differential distribution of Bag6 are 
important questions for future studies. 
 
Materials and Methods 
Detailed descriptions of experiments are provided in SI Materials and Methods. Briefly, 
for crystallization and in vitro binding assays human genes were subcloned and 
expressed in E. coli. Proteins were purified using affinity chromatography, anion-
exchange, and size-exclusion chromatography. Truncated fragments of Bag6 and TRC35 
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were crystallized and the structure was determined using molecular replacement single 
wavelength anomalous dispersion. The genomes were surveyed for TRC proteins using 
MEME suite (54). The immunoprecipitation assays were carried out using 293T cell 
extracts. A combination of three siRNAs against RNF126 was added to 293T cells. 10 
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Figure Legends  
Figure 1. The structure of the Bag6NLS-TRC35 heterodimer. 
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(A) The structure of Saccharomyces cerevisiae Get4-Get5N complex (PDBID: 3LKU), 
Get4 in rainbow and Get5 in magenta. Sequence alignment of TRC35/Get4 from helix 11 
to 12 of two metazoan species, Hsap (Homo sapiens), Aque (Amphimedon 
queenslandica), and six fungal species Spom (Schizosaccharomyces pombe), Ncas 
(Naumovozyma castelli), Scer (Saccharomyces cerevisiae), Afum (Aspergillus fumigatus), 
Ncra (Neurospora crassa), and Smus (Sphaerulina musiva). The secondary structure 
based on fungal Get4s is highlighted above the text. (B) Left, the overall structure of Bag6-
TRC35 heterodimer in cylinder representation with Bag6 in light pink and TRC35 in 
rainbow. The nuclear localization sequence is highlighted in sticks on Bag6. Right, a 90˚ 
in plane rotated ‘bottom’ view. The 16 helices of TRC35 are labeled from N to C terminus. 
(C) Comparison of the C-terminal faces of TRC35 and Get4 that bind Bag6 and Get5, 
respectively. The arrows highlight the significant structural difference in the residues 
between α11 and α12. (D) Zoomed in view of the regions, defined as interface I and II. 
Hydrophobic residues that are involved in Bag6-TRC35 dimerization are shown as sticks.  
 
Figure 2. Validation of the Bag6-TRC35 interface. 
(A) Yeast 2-hybrid assay to validate the interface identified in the crystal structure. Wild-
type TRC35 conjugated to the DNA binding domain was expressed with wild-type or 
mutant Bag6(951-1126) conjugated to the transcription activating domain. Interaction was 
determined by ability to grow on adenine(-) media. (B) Wild-type or mutant Bag6•GFP 
was co-expressed in Bag6-/- 293T cells with TRC35•FLAG and immunoprecipitated using 
anti-GFP antibody. Amount of TRC35 retrieved by Bag6 was assessed by blotting with 
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anti-FLAG antibody. The position of the higher molecular weight TRC35•FLAG is 
highlighted with an asterisk.  
 
Figure 3. Ubiquitylation of TRC35 in cells expressing Bag6 mutants is dependent 
on RNF126. 
(A) Bag6-/- 293T cells co-transfected with plasmids encoding TRC35•FLAG (wt), 
Bag6•GFP (wt or mutant), and HA•ubiquitin and treated with 10 µM MG132. The cell 
extracts were subject to two rounds of immunoprecipitation with anti-GFP antibody then 
with anti-FLAG antibody in denaturing conditions. Ubiquitylation was assessed by 
immunoblotting with HA antibody. (B) Bag6-/- 293T cells co-transfected with plasmids 
encoding TRC35•FLAG (wt), Bag6•GFP (wt or mutants), and HA•ubiquitin. The cells were 
simultaneously treated with 10 µM MG132 and siRNAs against RNF126. The cell extracts 
were subject to two rounds of denaturing immunoprecipitation with anti-GFP antibody 
then with anti-FLAG antibody. TRC35 ubiquitylation was assessed by immunoblotting 
with HA antibody.  
 
Figure 4. Bag6 mutations at the TRC35 binding site results in nuclear localization 
of Bag6. 
(A-F) Representative images of Cos7 cells expressing wtTRC35•FLAG and wt or mutant 
Bag6•GFP. Cos7 cells were transfected either with Bag6•GFP (wt or mutant) expressing 
plasmid alone or co-transfected with TRC35•FLAG (wt) expressing plasmid. Cells were 
stained with anti-GFP (green) and/or anti-FLAG (red) antibodies. DNA was stained with 
DAPI where indicated (blue). In the Bag6 column, the percent of cells that contain nuclear 
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Bag6 is noted in parenthesis. For each Bag6 variant, approximately 100 cells were 
counted and categorized as having nuclear or cytosolic Bag6.  
 
Figure 5. Bag6 is required for TRC35 stability and TRC35 binding precludes 
karyopherin α binding to Bag6. 
 (A) The putative bipartite nuclear localization sequence of Bag6. The serine and leucine 
mutations introduced in this study are highlighted. (B) Recombinantly purified Bag6C131-
6xHis•Ubl4A (500 pmol) was incubated with two-fold excess GST•TRC35 or MBP•KPNA2 
for 20 minutes at room temperature. Ni-NTA beads were used to capture purified 
Bag6C131-6xHis•Ubl4A and bound factors. (C) Recombinantly purified Bag6C131-
6xHis•Ubl4A (500 pmol) was first incubated with either GST•TRC35 or MBP•KPNA2 (500 
pmol). The resulting GST•TRC35-Bag6C131-6xHis•Ubl4A complex was incubated with 
glutathione resin beads, and increasing amounts of MBP•KPNA2 (50 pmol, 250 pmol, or 
1000 pmol) was added. The ability of MBP•KPNA2 to displace Bag6C131-6xHis•Ubl4A 
from GST•TRC35 was examined by eluting the GST•TRC35 and bound Bag6C131-
6xHis•Ubl4A from the glutathione resin. The opposite experiment was also carried out 
using amylose resin beads.  
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Aque ------------------------   271
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Scer ------------------------   312
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Table S1. Crystallographic Analysis 
 Native  Rubidium 
Data collection   
Protein Bag6-TRC35 Bag6-TRC35 
Synchrotron SSRL SSRL 
Beamline 12-2 12-2 
Space group P21 21 21 P21 21 21 
Cell dimensions   
    a, b, c (Å) 41.7, 84.6, 102.6 42.0, 84.3, 102.5 
    a, b, g (°) 90.0 90.0, 90.0 90.0, 90.0, 90.0 
   
Wavelength 0.9200 0.8154 
Resolution (Å) 39.1 – 1.80 (1.92 – 1.80) 50.0 – 1.99 (2.11 – 1.99)  
Rmeas (%)a 9.3 (64.3) 16.9 (118.8) 
I  /  s(I)  16.9 (3.8) 14.9 (2.1) 
CC1/2 (%) 99.9 (95) 99.9 (88.0) 
Completeness (%)a 98.7 (92.7) 99.2 (95.6) 
No. of observations 384,047 (60,190) 655,714 (96,962) 
No. of unique reflections a 40,776 (6,194) 47,793 (7,417) 




Refinement   
Resolution (Å) 39.1 – 1.80  
No. of reflections 34,334  
No. of reflections test set 1,998  
Rwork / Rfree 16.0 / 20.0  
No. atoms (non-hydrogen) 2725  
    Protein 2561  
    Water 152  
    Ligand/Ions 12  
B-factors   
    Protein 31.7  
    Water 39.0  
RMSD   
    Bond lengths (Å)  0.010  
    Bond angles (°) 1.16  
   
Ramachandran plotd   
    Favored (%) 98  
    Additionally allowed (%) 2.0  
    Outliers (%) 0.0  
aHighest-resolution shell is shown in parentheses 
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Table	S2
TRC35 Ubl4A SGTA TRC40 Bag6
Homo	sapiens NP_057033.2 NP_055050.1 NP_003012.1 NP_004308.2 NP_004630.3
Gallus	gallus XP_015149638.1 XP_015129423.1 NP_001026550.2 XP_015158190.1
Branchiostoma	floridae XP_002607071.1 XP_002594764.1 XP_002591391.1 XP_002605952.1 XP_002594881.1
Drosophila	melanogaster NP_649464.1 NP_650680.1 NP_609842.1 NP_610296.2 NP_648132.2
Caenorhabditis	elegans NP_498034.1 NP_494893.1 NP_498965.1
Schistosoma	mansoni XP_018645653.1 XP_018645468.1 XP_018654909.1 XP_018648676.1 XP_018648249.1
Nematostella	vectensis XP_001640454.1 XP_001638929.1 XP_001638254.1 XP_001635433.1
Amphimedon	queenslandica XP_011404841.1 XP_003387439.1 XP_003385895.1
Monosiga	brevicollis XP_001750773.1 jgi	Monbr1	37257 XP_001743630.1
Capsaspora	orwazaki XP_004342754.1 XP_004347862.1 XP_004343568.1 XP_004363354.1
Fonticula	alba KCV72828.1 XP_009498174.1 XP_009492379.1
Saccharomyces	cerevisiae NP_014807.3 NP_014807.3 NP_014649.1 NP_010183.1
Dictyostelium	discoideum XP_640617.1 XP_642815.1 XP_641391.1 XP_629069.1
Trypanosoma	brucei XP_845518.1
Plasmodiophora	brassicae CEP00951.1 CEP02084.1 CEP01962.1 CEP03329.1
Tetrahymena	thermophila XP_012656464.1 XP_001033080.2
Arabidopsis	thaliana	 NP_201127.2 NP_192572.2 NP_563640.1
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Table S3
Cytosolic Bag6 (# of cells) Nuclear Bag6 (# of cells) Total # of cells
wtBag6 77 7 84
Bag6(W1004A) 50 30 80
Bag6(W1012A) 35 65 100
Bag6(Y1036A) 32 56 88
Bag6(W1004A/1036A) 18 113 131
Bag6(W1012A/1036A) 15 137 152
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